Categories: News

Nobel Prize 2025 in Medicine: Three Scientists Who Changed the Future of Immunology

The Nobel Prize 2025has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi — three brilliant scientists who unlocked one of biology’s greatest mysteries:
How does the immune system defend us without attacking our own body?

- Advertisement -

- Advertisement -

- Advertisement -

Their groundbreaking discovery of Regulatory T-cells (Tregs) and the FOXP3 gene has transformed modern medical science.

- Advertisement -

🧠 The Discovery: Body’s Built-in Brake System

In 1995, Shimon Sakaguchi identified a unique group of immune cells — Regulatory T-cells — that act as a “brake system” for our immunity, keeping it from going out of control.
Later in 2001, Mary E. Brunkow and Fred Ramsdell discovered the FOXP3 gene, which controls these T-cells.
When this gene malfunctions, the immune system attacks the body — leading to deadly autoimmune diseases like IPEX Syndrome.

- Advertisement -

💉 Impact on Medicine

This discovery has revolutionized the way scientists understand and treat diseases.
It has opened new pathways for therapies that aim to activate or control Regulatory T-cells — a potential cure for autoimmune disorders, cancer, and organ transplant rejection.

- Advertisement -

This isn’t just a scientific achievement; it’s the dawn of a medical revolution that will define the future of healthcare.

- Advertisement -

📅 Upcoming Nobel Announcements

  • Physics – October 8
  • Chemistry – October 9
  • Literature – October 10
  • Peace – October 11
  • Economics – October 13

The scientific community now eagerly awaits the rest of the Nobel week.

- Advertisement -

The story of these Nobel laureates reminds us — every big discovery begins with a small question.
And who knows… the next Nobel winner might just be from India! 🇮🇳

- Advertisement -

- Advertisement -
lifecarenews

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

1 week ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

3 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago